Therapeutic options for IPF

U. Costabel (Essen, Germany)

Source: Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis
Session: PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis
Session type: Postgraduate Course
Number: 5
Disease area: Interstitial lung diseases

Slide presentationPDF journal article, handout or slidesMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Costabel (Essen, Germany). Therapeutic options for IPF. Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Samuel Pecho Silva - 20.12.2010 23:34
It give a new perspective in the management of this sad disease. i will be interesting in have the opinion about the use of macrolide plus protomp pump inhibitor plus low dose of prednisone (10 mg per day) in patients with IPF with panalization and no option of pirfenidone neither clinical trials.
You must Login to comment this presentation.


Related content which might interest you:
Therapeutic implications
Source: Annual Congress 2011 - Why are small airways important in asthma? An ERS/World Allergy Organization joint symposium
Year: 2011


Current controversies in the treatment of COPD
Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD
Year: 2011

Surgical options
Source: Annual Congress 2010 - PG19 Postgraduate Course: Treatment of obstructive sleep apnoea
Year: 2010



Challenges in IPF trials: the point on endpoints
Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions
Year: 2010

The diagnosis of IPF: recommendations & rationale
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010


New approaches for diagnosis and management of COPD
Source: Annual Congress 2010 - GOLD Update
Year: 2010

Overview of treatment modalities
Source: Annual Congress 2011 - PG15 Treatment of obstructive sleep apnoea
Year: 2011



Overview of treatment modalities
Source: Annual Congress 2010 - PG19 Postgraduate Course: Treatment of obstructive sleep apnoea
Year: 2010



Pulmonary fibrosis: ongoing trials and future treatment
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010

Therapeutic options for COPD exacerbations
Source: International Congress 2014 – PG04 Update on COPD exacerbations
Year: 2014




Follow-up and nonpharmacological management of the IPF patient
Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions
Year: 2010

Novel treatments for IPF
Source: International Congress 2014 – ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)"
Year: 2014



Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses
Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010
Year: 2010


Specific pleural problems after surgical treatment
Source: Annual Congress 2011 - PG7 An update on pleural problems
Year: 2011